Idexx Laboratories (IDXX) Stock Forecast & Price Target
IDXX Analyst Ratings
Moderate Buy
6Buy4Hold0Sell
Based on 10 analysts giving stock ratings to Idexx Laboratories in the past 3 months
IDXX Stock 12 Month Forecast
Average Price Target
MXN 13,085.63â–²(23.81% Upside)Based on 10 Wall Street analysts offering 12 month price targets for Idexx Laboratories in the last 3 months. The average price target is MXN 13,085.63 with a high forecast of MXN 14,936.45 and a low forecast of MXN 11,633.73. The average price target represents a 23.81% change from the last price of MXN 10,569.17.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 14.94K
AverageMXN 13.09K
LowMXN 11.63K
Highest Price TargetHighestMXN 14,936.45Average Price TargetMXN 13,085.63Lowest Price TargetLowestMXN 11,633.73
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Andrea Alfonso | UBS | MXN 12,431.58→MXN 11,633.73 | hold | 10.07%Upside | Assigned | 10/27/26 | ||
| Chris Schott | J.P. Morgan | MXN 14,379.81→MXN 13,915.95 | buy | 31.67%Upside | Assigned | 10/16/26 | ||
| Matthew Dellatorre | Goldman Sachs | MXN 13,730.40 | buy | 29.91%Upside | Initiated | 10/15/26 | ||
| Scott Schoenhaus | KeyBanc | ― | hold | ― | Initiated | 10/12/26 | ||
| Ryan Daniels | William Blair | ― | buy | ― | Reiterated | 10/02/26 | ||
| Jonathan Block | Stifel Nicolaus | MXN 12,524.35 | buy | 18.50%Upside | Reiterated | 08/14/26 | ||
| Michael Ryskin | Bank of America Securities | MXN 12,246.03→MXN 12,338.81 | hold | 16.74%Upside | Reiterated | 08/14/26 | ||
| Glen Santangelo | Barclays | MXN 13,173.76 | buy | 24.64%Upside | Reiterated | 08/11/26 | ||
| Daniel Grosslight | Citi | MXN 12,060.49→MXN 12,431.58 | hold | 17.62%Upside | Reiterated | 08/05/26 | ||
| Erin Wright | Morgan Stanley | MXN 14,936.45 | buy | 41.32%Upside | Reiterated | 08/05/26 | ||
| Keith Devas | Jefferies | MXN 14,695.24 | buy | 39.04%Upside | Reiterated | 05/06/26 | ||
| David Westenberg | Piper Sandler | MXN 14,379.81→MXN 13,915.95 | hold | 31.67%Upside | Reiterated | 02/09/26 | ||
| Mark Massaro | BTIG | MXN 15,400.32→MXN 14,843.68 | buy | 40.44%Upside | Reiterated | 02/03/26 | ||
| Daniel Clark | Leerink Partners | MXN 13,823.17→MXN 14,565.36 | buy | 37.81%Upside | Reiterated | 11/03/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Andrea Alfonso | 10/27/26 | MXN 12,431.58→MXN 11,633.73 | hold | 10.07%Upside | Assigned | UBS | ||
| Chris Schott | 10/16/26 | MXN 14,379.81→MXN 13,915.95 | buy | 31.67%Upside | Assigned | J.P. Morgan | ||
| Matthew Dellatorre | 10/15/26 | MXN 13,730.40 | buy | 29.91%Upside | Initiated | Goldman Sachs | ||
| Scott Schoenhaus | 10/12/26 | ― | hold | ― | Initiated | KeyBanc | ||
| Ryan Daniels | 10/02/26 | ― | buy | ― | Reiterated | William Blair | ||
| Jonathan Block | 08/14/26 | MXN 12,524.35 | buy | 18.50%Upside | Reiterated | Stifel Nicolaus | ||
| Michael Ryskin | 08/14/26 | MXN 12,246.03→MXN 12,338.81 | hold | 16.74%Upside | Reiterated | Bank of America Securities | ||
| Glen Santangelo | 08/11/26 | MXN 13,173.76 | buy | 24.64%Upside | Reiterated | Barclays | ||
| Daniel Grosslight | 08/05/26 | MXN 12,060.49→MXN 12,431.58 | hold | 17.62%Upside | Reiterated | Citi | ||
| Erin Wright | 08/05/26 | MXN 14,936.45 | buy | 41.32%Upside | Reiterated | Morgan Stanley | ||
| Keith Devas | 05/06/26 | MXN 14,695.24 | buy | 39.04%Upside | Reiterated | Jefferies | ||
| David Westenberg | 02/09/26 | MXN 14,379.81→MXN 13,915.95 | hold | 31.67%Upside | Reiterated | Piper Sandler | ||
| Mark Massaro | 02/03/26 | MXN 15,400.32→MXN 14,843.68 | buy | 40.44%Upside | Reiterated | BTIG | ||
| Daniel Clark | 11/03/25 | MXN 13,823.17→MXN 14,565.36 | buy | 37.81%Upside | Reiterated | Leerink Partners |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Idexx Laboratories
3 Months
Success Rate7/9 ratings generated profit
78%
Average Return
+7.60%
Copying Daniel Clark's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +7.60% per trade.
1 Year
Success Rate27/36 ratings generated profit
75%
Average Return
+24.85%
Copying Jonathan Block's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +24.85% per trade.
2 Years
Success Rate26/36 ratings generated profit
72%
Average Return
+54.21%
Copying Jonathan Block's trades and holding each position for 2 Years would result in 72.22% of your transactions generating a profit, with an average return of +54.21% per trade.
IDXX Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 6 | 7 | 7 | 8 |
| Hold | 5 | 3 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 9 | 12 | 13 | 14 |
In the current month, IDXX has received 8 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. IDXX average Analyst price target in the past 3 months is 13,085.63.
IDXX Financial Forecast
HighMXN 66.32
ConsensusMXN 63.82
LowMXN 62.77
IDXX Earnings Forecast
Next quarter’s earnings estimate for IDXX is MXN 63.82 with a range of MXN 62.77 to MXN 66.32. The previous quarter’s EPS was MXN 75.36. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 22.3B
ConsensusMXN 22.1B
LowMXN 21.9B
IDXX Sales Forecast
Next quarter’s sales forecast for IDXX is MXN 22.07B with a range of MXN 21.91B to MXN 22.27B. The previous quarter’s sales results were MXN 22.74B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
IDXX Stock Forecast FAQ
What is MX:IDXX’s average 12-month price target, according to analysts?
Based on analyst ratings, Idexx Laboratories’s 12-month average price target is Mex$13,085.63.
What is MX:IDXX’s upside potential, based on the analysts’ average price target?
Idexx Laboratories has 23.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Idexx Laboratories a Buy, Sell or Hold?
Idexx Laboratories has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 0 sell ratings.
What is Idexx Laboratories’s share price target?
The average share price target for Idexx Laboratories is Mex$13,085.63. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$14,936.45, and the lowest forecast is Mex$11,633.73. The average share price target represents a 23.81% increase from the current price of Mex$10,569.17.
What do analysts say about Idexx Laboratories?
Idexx Laboratories’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Idexx Laboratories?
To buy shares of MX:IDXX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
